NDC codes

FDA NDC Directory
Product NDC (as listed)69616-211Labeler and product segments. Claims need a package NDC.
Product NDC at billing width69616-0211Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
69616-211-0369616021103240 TABLET in 1 BOTTLE, PLASTIC (69616-211-03)Marketed from Jan 7, 2019
69616-211-066961602110612 BLISTER PACK in 1 CARTON (69616-211-06) / 10 TABLET in 1 BLISTER PACK (69616-211-04)Marketed from Jan 7, 2019
69616-211-086961602110860 TABLET in 1 BOTTLE, PLASTIC (69616-211-08)Marketed from Jan 7, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Firdapse
Generic name (nonproprietary)
amifampridine phosphate
Active ingredients
Amifampridine phosphate — 10 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Catalyst Pharmaceuticals, Inc.NDC labeler code 69616
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 208078
Marketing start
Listing expires
Other FDA classes
Potassium Channel Antagonists (Mechanism)
Identifiers
Product ID 69616-211_4f94edd2-b6a8-264d-e063-6294a90a89dfSPL ID 4f94edd2-b6a8-264d-e063-6294a90a89dfSPL set ID f015fe60-3128-4a43-8c31-19fc6b5def3fRxCUI 2106343, 2107518UNII 8HF8FIN815
Pharmacologic class
Potassium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469616021103 followed by a unit qualifier and the quantity

Package 69616-0211-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

FIRDAPSE ® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69616-211

What is NDC 69616-211?
69616-211 is the product NDC for Firdapse (amifampridine phosphate), Amifampridine phosphate 10 mg/1 tablet, listed with the FDA by Catalyst Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Firdapse (Amifampridine phosphate).
What is the active ingredient?
Amifampridine phosphate.
Who is the labeler?
Catalyst Pharmaceuticals, Inc., NDC labeler code 69616. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Firdapse?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in